Document is current

Any future updates will be listed below

Correction: Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax

Crossref DOI link: https://doi.org/10.1186/s12967-025-07052-7

Published Online: 2025-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark